The Last 10 Days of Patients With Glioblastoma: Assessment of Clinical Signs and Symptoms as well as Treatment

American Journal of Hospice and Palliative Medicine

Volumn 33, Issue 10, 2016, Pages 985-988

  Thier, Katrin ^a   Calabek, Bernadette ^a   Tinchon, Alexander ^a   Grisold, Wolfgang ^b   Oberndorfer, Stefan ^a  

^a KLPU and Karl Landsteiner Institute for Clinical Neurology and Neuropsychology   (Austria)

^b KAISER FRANZ JOSEF HOSPITAL   (Austria)

Author keywords

end of life; glioblastoma; palliative care; supportive care

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; BRAIN TUMOR; COMPLICATION; DEGLUTITION DISORDERS; FEMALE; FEVER; FLUID THERAPY; GLIOBLASTOMA; HUMAN; MALE; MIDDLE AGED; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; QUALITY OF LIFE; SEIZURES; TERMINAL CARE; UNCONSCIOUSNESS; VITAL SIGN;

ADRENAL CORTEX HORMONES; AGED; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICONVULSANTS; BRAIN NEOPLASMS; DEGLUTITION DISORDERS; FEMALE; FEVER; FLUID THERAPY; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEIZURES; TERMINAL CARE; UNCONSCIOUSNESS; VITAL SIGNS;

EID: 84994071402     PISSN: 10499091     EISSN: 19382715     Source Type: Journal    
DOI: 10.1177/1049909115609295     Document Type: Article

References (21)

1. Ostrom QT, Gittleman H, Liao P. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the united states in 2007-2011. Neuro Oncol. 2014;16(4):1–63.
2. Stupp R, Mason WP, van den Bent MJ. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987–996.
3. Oberndorfer S, Lahrmann H. Supportive therapie und palliativmedizin bei patienten mit malignen gliomen. Wien Med Wochenschr. 2006;156(11-12):364–368.
4. Walbert T. Integration of palliative care into the neuro-oncology practice: patterns in the United States. Neurooncol Pract. 2014;1(1):3–7.
5. Ostgathe C, Gaertner J, Kotterba M. Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer. 2010;18(9):1157–1163.
6. Janda M, Steginga S, Dunn J, Langbecker D, Walker D, Eakin E. Unmet supportive care needs and interest in services among patients with a brain tumour and their carers. Patient Educ Couns. 2008;71(2):251–258.
7. Flechl B, Ackerl M, Sax C. The caregivers’ perspective on the end-of-life phase of Glioblastoma patients. J Neurooncol. 2013;112(3):403–422.
8. Oberndorfer S, Lindeck-Pozza E, Lahrmann H, Struhal W, Hitzenberger P, Grisold W. The End-of-Life Hospital Setting in Patients with Glioblastoma. J Palliat Med. 2008;11(1):26–30.
9. Sizoo EM, Braam L, Postma TJ. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol. 2010;12(11):1162–1166.
10. Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol. 2014;117(2):217–224.
11. Sizoo EM, Koekkoek JA, Postma TJ. Seizures in patients with high-grade glioma: a serious challenge in the end-of-life phase. BMJ Support Palliat Care. 2014;4(1):77–80.
12. Pace A, Villani V, Di Lorenzo C. Epilepsy in the end-of-life phase in patients with high-grade gliomas. J Neurooncol. 2013;111(1):83–86.
13. Koekkoek JA, Dirven L, Reijneveld JC. Epilepsy in the end of life phase of brain tumor patients: a systematic review. Neuro Oncol Pract. 2014;1(3):134–140.
14. Pace A, Metro G, Fabi A. Supportive care in neurooncology. Curr Opin Oncol. 2010;22(6):621–626.
15. Sizoo EM, Taphoorn MJB, Uitdehaag B. The end-of-life phase of high-grade glioma patients: dying with dignity? Oncologist. 2013;18(2):198–203.
16. Koekkoek JA, Dirven L, Reijneveld JC. End of life care in high-grade glioma patients in three European countries: a comparative study. J Neurooncol. 2014;120(2):303–310.
17. Pace A, Di Lorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A. End of life issues in brain tumor patients. J Neurooncol. 2009;91(1):39–43.
18. Koekkoekk JA, Dirven L, Sizoo EM. Symptoms and medication management in the end of life phase of high-grade glioma patients. J Neurooncol. 2014;120(3):589–595.
19. Daly FN, Schiff D. Supportive management of patients with brain tumors. Expert Rev Neurother. 2007;7(10):1327–1336.
20. World Health Organization. Cancer Pain Relief. 2nd ed. Geneva: World Health Organization;1996.
21. Van Breemen M, Rijsman R, Taphoorn M, Walchenbach R, Zwinkels H, Vecht CJ. Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol. 2009;256(9):1519–1526.